These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 23377404)

  • 1. Clocortolone pivalate: a topical corticosteroid with a unique structure.
    Kircik LH
    J Drugs Dermatol; 2013 Feb; 12(2):s3-4. PubMed ID: 23377404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The treatment of inflammatory facial dermatoses with topical corticosteroids: focus on clocortolone pivalate 0.1% cream.
    Kircik LH; Del Rosso JQ
    J Drugs Dermatol; 2012 Oct; 11(10):1194-8. PubMed ID: 23134984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of a midpotency topical corticosteroid and the clinical relevance of formulation characteristics in the management of commonly encountered eczematous and inflammatory dermatoses in adults and children: focus on the pharmacologic properties of clocortolone pivalate 0.1% cream.
    Del Rosso JQ; Kircik LH
    J Drugs Dermatol; 2013 Feb; 12(2):s5-s10. PubMed ID: 23377405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of clocortolone pivalate 0.1 percent cream in the treatment of atopic dermatitis, contact dermatitis, and seborrheic dermatitis.
    Nierman MM
    Cutis; 1981 Jun; 27(6):670-1. PubMed ID: 6453703
    [No Abstract]   [Full Text] [Related]  

  • 5. A Comprehensive Review of Clocortolone Pivalate 0.1% Cream: Structural Development, Formulation Characteristics, and Studies Supporting Treatment of Corticosteroid-responsive Dermatoses.
    Del Rosso JQ; Kircik L
    J Clin Aesthet Dermatol; 2012 Jul; 5(7):20-4. PubMed ID: 22798972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transitioning from brand to generic with topical products and the importance of maintaining the formulation and therapeutic profiles of the original product: focus on clocortolone pivalate 0.1% cream.
    Del Rosso JQ; Kircik LH
    J Drugs Dermatol; 2014 Jul; 13(7):s77-83. PubMed ID: 25007376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of three impurities in clocortolone pivalate.
    Xu W; Jia X; Liu W; Zhang X; Chen Y; Zhou L; You S
    J Pharm Biomed Anal; 2012 Mar; 62():167-71. PubMed ID: 22264563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study to assess the occlusivity and moisturization potential of three topical corticosteroid products using the skin trauma after razor shaving (STARS) bioassay.
    Kircik LH
    J Drugs Dermatol; 2014 May; 13(5):582-5. PubMed ID: 24809882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clocortolone pivalate cream 0.1% used concomitantly with tacrolimus ointment 0.1% in atopic dermatitis.
    Torok HM; Maas-Irslinger R; Slayton RM
    Cutis; 2003 Aug; 72(2):161-6. PubMed ID: 12953943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Multicentre-clinical trial of the novel corticosteroid diflucortolone valerate in the forms of cream, ointment and fatty ointment. Part I: Comparative study of diflucortolone valerate with fluocortolone, -capronate, -pivalate in a double-blind contralateral design with topical application (author's transl)].
    Reckers VR; Wendt H
    Arzneimittelforschung; 1976; 26(7b):1499-504. PubMed ID: 795433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clocortolone pivalate: a paired comparison clinical trial of a new topical steroid in eczema/atopic dermatitis.
    Rosenthal AL
    Cutis; 1980 Jan; 25(1):96-8. PubMed ID: 6986236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to clocortolone pivalate cream 0.1% in a pediatric population with atopic dermatitis.
    Conde JF; Kaur M; Fleischer AB; Tusa MG; Camacho F; Feldman SR
    Cutis; 2008 May; 81(5):435-41. PubMed ID: 18543596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temetex in the treatment of steroid-responsive dermatoses.
    Bergson VS; Franklin WH
    J Int Med Res; 1977; 5(1):33-6. PubMed ID: 138609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new topical corticosteroid.
    Med Lett Drugs Ther; 1982 Nov; 24(623):103-4. PubMed ID: 7144689
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical utility of clocortolone pivalate for the treatment of corticosteroid-responsive skin disorders: a systematic review.
    Singh S; Mann BK
    Clin Cosmet Investig Dermatol; 2012; 5():61-8. PubMed ID: 22791998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bouble-blind unilateral comparison of difluocortolone valerate and flumethasone pivalate ointments].
    Ruiz EM; Alaniz JB; Alvarez EG
    Z Hautkr; 1976; 51 Suppl 1():51-5. PubMed ID: 795190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of difluocortolone valerate chlorquinaldol cream in dermatoses with aggregate complications].
    Carvajal Rosado M
    Prensa Med Mex; 1977; 42(1-2):100-2. PubMed ID: 331299
    [No Abstract]   [Full Text] [Related]  

  • 18. [Topical treatment of various dermatoses with 0.1% difluocartolone valerate with 1% chlorquinaldol (cream)].
    Ogarrio González SR
    Prensa Med Mex; 1977; 42(1-2):103-5. PubMed ID: 896646
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical trial of fluocortin butylester in a double-blind contralateral comparison versus fluocortolone and hydrocortisone acetate (author's transl)].
    Reckers R
    Arzneimittelforschung; 1977; 27(11a):2240-4. PubMed ID: 341901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The use of difluocortolone valerate in various dermatoses].
    Ocampo FA
    Z Hautkr; 1976; 51 Suppl 1():17-9. PubMed ID: 795180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.